Novo Nordisk A/S: all 1,444 studies

Page 4 of 15. Open to participants first (108), then studies with results posted, then the rest; newest registration first within each.

• Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes PatientsCompletedNCT01589653Phase 4Results posted
• Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 DiabetesCompletedNCT01572740Phase 3Results posted
• A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose InsulinCompletedNCT01570751Phase 3Results posted
• A Trial Comparing the Efficacy of Insulin Degludec With Insulin Glargine on Glycaemic Control Using Continuous Glucose Monitoring in Patients With Type 1 DiabetesCompletedNCT01569841Phase 3Results posted
• Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep ApnoeaCompletedNCT01557166Phase 3Results posted
• Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 DiabetesCompletedNCT01541215Phase 3Results posted
• Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and MetforminCompletedNCT01519674Phase 4Results posted
• A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 DiabetesCompletedNCT01513590Phase 3Results posted
• A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes MellitusCompletedNCT01513473Phase 3Results posted
• Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD AloneCompletedNCT01512108Phase 3Results posted
• Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia ACompletedNCT01493778Phase 3Results posted
• Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A.CompletedNCT01489111Phase 3Results posted
• Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 DiabetesTerminatedNCT01486966Phase 4Results posted
• Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia ACompletedNCT01480180Phase 3Results posted
• Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy SubjectsCompletedNCT01473953Phase 1Results posted
• Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.CompletedNCT01467427Phase 3Results posted
• Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 DiabetesCompletedNCT01427920Phase 4Results posted
• Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773CompletedNCT01395810Phase 3Results posted
• A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 DiabetesCompletedNCT01392573Phase 3Results posted
• Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and InhibitorsCompletedNCT01392547Phase 3Results posted
• Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and MetforminCompletedNCT01388361Phase 3Results posted
• Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia BCompletedNCT01386528Phase 3Results posted
• Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing RegimensCompletedNCT01365507Phase 3Results posted
• Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes MellitusCompletedNCT01364428Phase 3Results posted
• Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 DiabetesCompletedNCT01336023Phase 3Results posted
• Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B PatientsCompletedNCT01333111Phase 3Results posted
• Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes MellitusCompletedNCT01326026Phase 3Results posted
• Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756CompletedNCT01278160Phase 4Results posted
• Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - DiabetesCompletedNCT01272232Phase 3Results posted
• Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetesCompletedNCT01272219Phase 3Results posted
• Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 DiabetesCompletedNCT01272193Phase 3Results posted
• Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit DeficiencyCompletedNCT01253811Phase 3Results posted
• Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or ParentsCompletedNCT01245374Phase 4Results posted
• Impact of Dietary Intervention on Weight Change in Subjects With Type 2 DiabetesCompletedNCT01232491Phase 4Results posted
• Safety of a Single Intravenous Dose of Recombinant Factor XIII in Children With Congenital FXIII A-subunit DeficiencyCompletedNCT01230021Phase 3Results posted
• Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs AloneCompletedNCT01215435Phase 4Results posted
• Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell TransplantationTerminatedNCT01206101Phase 2Results posted
• Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome ResultsCompletedNCT01179048Phase 3Results posted
• Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus RegimenCompletedNCT01165684Phase 4Results posted
• Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia ACompletedNCT01138501Phase 3Results posted
• Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)CompletedNCT01135992Phase 3Results posted
• Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin TreatmentCompletedNCT01123980Phase 4Results posted
• Comparison of NN1250 With Insulin Glargine in Type 1 DiabetesCompletedNCT01079234Phase 3Results posted
• Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT01076647Phase 3Results posted
• Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 DiabetesCompletedNCT01074268Phase 3Results posted
• Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT01068678Phase 3Results posted
• Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT01068665Phase 3Results posted
• Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic DrugsCompletedNCT01068652Phase 4Results posted
• A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01059812Phase 3Results posted
• Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT01059799Phase 3Results posted
• Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With InsulinCompletedNCT01046110Phase 3Results posted
• Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 DiabetesCompletedNCT01045707Phase 3Results posted
• Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 DiabetesCompletedNCT01045447Phase 3Results posted
• Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug TreatmentCompletedNCT01022762Phase 4Results posted
• Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01009580Phase 3Results posted
• Comparison of NN1250 With Insulin Glargine in Type 2 DiabetesCompletedNCT01006291Phase 3Results posted
• Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015CompletedNCT00984126Phase 3Results posted
• Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT00982644Phase 3Results posted
• Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 DiabetesCompletedNCT00982228Phase 3Results posted
• Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 DiabetesCompletedNCT00978627Phase 3Results posted
• Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725CompletedNCT00978380Phase 3Results posted
• Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 DiabetesCompletedNCT00972283Phase 3Results posted
• Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart SurgeryCompletedNCT00914589Phase 2Results posted
• Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00909480Phase 4Results posted
• PROPACT: Retrospective Prophylaxis Patient Case CollectionCompletedNCT00882778Results posted
• The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 DiabetesCompletedNCT00856986Phase 3Results posted
• Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen in Subjects With Type 2 Diabetes MellitusCompletedNCT00842361Phase 2Results posted
• Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 DiabetesCompletedNCT00841087Phase 2Results posted
• Safety and Efficacy of Turoctocog Alfa in Haemophilia A SubjectsCompletedNCT00840086Phase 3Results posted
• Safety, Tolerability and Pharmacokinetics of NN1731 in Healthy VolunteersCompletedNCT00822185Phase 1Results posted
• Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering DrugsCompletedNCT00819741Phase 4Results posted
• Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 DiabetesCompletedNCT00807092Phase 4Results posted
• Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin TreatmentCompletedNCT00795600Phase 4Results posted
• Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 DiabetesCompletedNCT00789191Phase 3Results posted
• Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - MaintenanceCompletedNCT00781937Phase 3Results posted
• Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in DiabeticsCompletedNCT00773279Phase 3Results posted
• Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited DeficiencyCompletedNCT00713648Phase 3Results posted
• Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With InhibitorsCompletedNCT00703911Results posted
• The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes MellitusCompletedNCT00700817Phase 3Results posted
• A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and LiraglutideCompletedNCT00696657Phase 2Results posted
• Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal InsulinCompletedNCT00669864Phase 4Results posted
• Observational Study to Evaluate the Safety of Levemir® in DiabetesCompletedNCT00659295Results posted
• Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once DailyCompletedNCT00634842Phase 4Results posted
• Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00627445Phase 3Results posted
• Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689CompletedNCT00623194Phase 3Results posted
• The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes MellitusCompletedNCT00620282Phase 3Results posted
• Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00614120Phase 3Results posted
• Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 DiabetesCompletedNCT00614055Phase 2Results posted
• Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 DiabetesCompletedNCT00613951Phase 2Results posted
• Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 DiabetesCompletedNCT00612040Phase 2Results posted
• Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 DiabetesCompletedNCT00611884Phase 2Results posted
• Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing TrialCompletedNCT00542620Phase 4Results posted
• Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 DiabetesCompletedNCT00537303Phase 4Results posted
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADsCompletedNCT00537277Phase 4Results posted
• Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00518882Phase 3Results posted
• Effect of Insulin Detemir on Use of Energy in Type 1 DiabetesTerminatedNCT00509925Phase 4Results posted
• Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 DiabetesTerminatedNCT00506662Phase 4Results posted
• The Effect of Somatropin Treatment in Adult Patients on Chronic DialysisTerminatedNCT00503698Phase 3Results posted
• Haemophilia Patients With Inhibitors Being Treated for Acute Joint BleedsCompletedNCT00486278Phase 2Results posted
• Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 DiabetesCompletedNCT00474045Phase 3Results posted

← Novo Nordisk A/S overview and focus areas